Cereno Scientific publishes the interim report for Q2 2023 ( April 1 – June 30)
The Board and Chief Executive Officer of Cereno Scientific AB here present the interim report for Q2 2023 ( April 1 – June 30).Summary of the interim report for Q2 2023 ( April 1 – June 30) Cereno Scientific Group · Result after financial items was SEK 10,686,053 (-6,518,033) · Earnings per share was SEK -0.05 (-0.06) before dilution and SEK -0.04 (-0.04) after dilution · The equity/assets ratio was 95.4% (93.2%) · Cash and bank balance was SEK 85,291,722 SEK (63,257,948) Parent company · Result after financial items was SEK -10,697,871 (-6,747,978) · Earnings